40.41
BATS BZX Real-Time Price
As of 1:52pm ET
 -0.04 / -0.10%
Today’s Change
25.04
Today|||52-Week Range
43.16
+19.56%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$9.3B

Company Description

QIAGEN NV is a holding company, which engages in the provision of sample and assay technology to transform biological samples into valuable molecular insights. It offers bioinformatics, molecular diagnostics, next-gen sequencing, and genomic services. The company was founded by Detlev H. Riesner and Metin Colpan on April 29, 1996 and is headquartered in Venlo, the Netherlands.

Contact Information

QIAGEN NV
Hulsterweg 82
Venlo Limburg 5912 PL
P:(177) 355-6600
Investor Relations:
(177) 355-6666

Employees

Shareholders

Mutual fund holders50.00%
Other institutional28.93%
Individual stakeholders--

Top Executives

There are no executives to display.